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Background: Chronic back pain continues to be a costly and prevalent condition. The latest NICE guidelines issued
in 2009 state that for patients with persistent back pain (of between six weeks and twelve months duration), who
are highly distressed and/or disabled and for whom exercise, manual therapy and acupuncture has not been
beneficial, the evidence supports a combination of around 100 hours of combined physical and psychological
treatment. This is costly, and may prove unacceptable to many patients. A key recommendation of these guidelines
was for further randomised controlled trials (RCTs) of psychological treatment and to target treatment to specific
sub-groups of patients. Recent trials that have included psychological interventions have shown only moderate
improvement at best, and results are not maintained long term. There is therefore a need to test theoretically
driven interventions that focus on specific high-risk sub-groups, in which the intervention is delivered at full
integrity against a credible control.
Methods/design: A feasibility study of a pragmatic randomised controlled trial comparing psychologist-delivered
Contextual Cognitive Behavioural Therapy (CCBT) against Treatment As Usual (TAU) physiotherapy delivered by
physiotherapists for the treatment of chronic lower back pain in ‘avoidant’ patients. Ninety-two patients referred for
physiotherapy will be recruited and randomised on a 1:1 basis to receive CCBT or TAU. Treatment groups will be
balanced by centre and pain interference score. Primary outcomes include assessing the credibility and
acceptability of the intervention, and to demonstrate proof of principle through a greater change in pain
acceptance in the CCBT arm, measured by the Acceptance and Action –II and the Chronic Pain Acceptance
questionnaires. In addition, the feasibility of carrying out a full trial will be explored with reference to recruitment
and follow-up rates including the assessment of the burden of outcome measure completion. Secondary patient
outcomes include disability, pain, fear of movement, mood, quality of life, and global recovery. Outcomes are
measured at three and six months post-randomisation.
Discussion: This paper details the rationale, design, therapist training system and recruitment methods to be used
in a feasibility study which will inform the design and efficient implementation of a future definitive RCT.
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Chronic musculoskeletal pain, including the primary
complaint of back pain, remains a costly and prevalent
problem. Back pain has been identified as a leading
cause of disability world-wide, with an estimated 632
million people affected [1]. During the course of one
year 20% of UK adults consult their General Practitioner
(GP) about a musculoskeletal problem, making this the
second most frequent reason for consultation after re-
spiratory disease. The most common musculoskeletal
presentation is spinal (low back and neck) pain, with
38% of adults affected in any one year at an estimated
cost to the National Health Service (NHS) of £1 billion
per annum [2].
There is an evidence-based consensus that certain psy-
chological factors (conceptualised as yellow flags [3]),
form obstacles to recovery, and should, therefore, be
targeted by interventions. In the UK, the National Insti-
tute for Health and Clinical Excellence (NICE) guide-
lines (2009) for the management of persistent low back
pain with a duration of six weeks to twelve months rec-
ommend a combination of physical and psychological
treatment for a sub-group of patients who are high in
disability and distress [4]. The evidence suggests that
around 100 hours of treatment over 8 weeks are benefi-
cial, but this is costly, and may prove unacceptable to
many patients. A key recommendation of these guide-
lines was for further randomised controlled trials (RCTs)
of psychological treatment. To date, the evidence from
trials of biological, psychological and social interventions
(and combinations of these) has been disappointing, in-
dicating at best small to moderate improvements in out-
comes when compared with treatment as usual. In
addition, these effects are often not maintained at long-
term follow up [5].
Systematic reviews of trials that have tested psycho-
logical interventions for chronic pain [6] report consider-
able gaps in the evidence, including failure to examine
long-term effects; failure to select appropriate risk-groups
that are most likely to benefit from the intervention; insuf-
ficient methodological quality; and little evidence to com-
pare directly the efficacy of different interventions.
Reviews recommend that future intervention should be
more focused and theory-driven. A consensus paper
attempting to clarify the disappointing results from psy-
chological interventions has emphasised the need for bet-
ter integrity in treatment delivery, and selection of at-risk
patients [7]. A recent trial has demonstrated that stratified
care is a promising approach: patients in the sub-groups
for targeted treatment for back pain screening (STarT
Back) trial were screened for low, medium and high risk,
the latter including psychological factors such as cata-
strophic thinking and low mood. The high-risk group re-
ceived CBT-informed physiotherapy. Overall, the trialdemonstrated that screening and matching treatment for
specific risk groups improved outcomes significantly more
than physiotherapy alone [8]. However, questions remain
about the optimal intervention for the high risk group, es-
pecially in reference to long-term outcomes.
We thus aimed to follow the recommendations for im-
proving trials of psychological treatment for high-risk
patients, by developing and testing an intervention that
is: theoretically driven; explicitly links the intervention to
a hypothesised risk factor in patients; where hypothesised
outcome can be measured reliably; delivered to a quality
that reflects the integrity of the intervention in reference
to training and content; methodologically implemented to
allow for adequate power to test the effectiveness of the
intervention; implementable in UK-based National Health
Service NHS settings; and is acceptable to patients.
We have identified a promising approach for treating a
sub-section of the high-risk group of patients. Contextual
Cognitive Behavioural Therapy (CCBT) is an approach
within the wider family of cognitive and behavioural ther-
apies, based on the treatment model of Acceptance and
Commitment Therapy (ACT) [9] and including methods
of mindfulness [10,11]. The intervention aims to increase
psychological flexibility and acceptance, thus impacting on
function and improving quality of life rather than reducing
pain. There is some evidence to suggest that the interven-
tion is promising, but there are no conclusive high- quality
RCTs carried out on at-risk (avoidant) patients in pain
populations. In addition, the level of acceptability to pa-
tients has not been assessed.
Although the intervention may be suitable for a variety
of high-risk groups, we elected to focus on a specific,
evidence-based risk factor, namely, avoidance. A funda-
mental aspect of both distress and disability is with-
drawal from and reduced participation in daily activity,
social contact and work. This avoidance process is con-
sidered a key obstacle to recovery, and is described in
the Fear Avoidance Model (FAM) [12]. CCBT conceptu-
alises fear avoidance processes in a wider form than the
standard FAM and changes the focus of traditional pain
management. In CCBT any psychological experiences
that coordinate avoidance can become the focus in treat-
ment with the emphasis on the influences exerted by
these experiences and not solely on changing their con-
tent or frequency. CCBT includes both traditional
methods for changing behaviour, and newer methods
developed from the theory underpinning ACT and
mindfulness. These newer methods are predominantly
experientially based, and address such processes as
acceptance and patient values [9,13-15]. CCBT also in-
cludes a specific approach to the therapeutic relations
designed to enhance treatment impact. The primary de-
fining feature of CCBT is that it is focused on enhancing
patient psychological flexibility.
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inform such a large trial the feasibility study described
below is being conducted.
Aims and objectives
The aim of this study is to test the acceptability and
credibility of CCBT against best-practice physiotherapy
(treatment as usual (TAU)) for people with chronic back
pain with associated avoidance of daily activities. In
addition, we aim to test the feasibility of implementing a
full scale RCT.
The primary objectives are:
 To determine whether CCBT is an acceptable and
credible intervention for NHS patients with
persistent back pain and avoidance in comparison
to TAU
 To assess recruitment processes and study uptake to
inform the feasibility of a definitive RCT
 To assess follow up response rates and level of
missing data
 To assess the burden of measurement tool
completion
 To demonstrate proof of principle by gathering
information about the process of change between
the two treatment arms (that is, whether the effect
of CCBT in enhancing acceptance post-intervention
is sufficiently promising compared to the control to
warrant a full trial)
The secondary objectives are to measure long-term
changes in quality of life outcomes relating to mood,
pain, disability and functioning.
Methods/design
Trial design
OBI is a pragmatic multi-centre randomised controlled
feasibility study that has been designed to assess the
methodology proposed for use in the definitive RCT.
Settings and participants
A total of 92 participants will be recruited from four
NHS musculoskeletal/physiotherapy services who have
agreed to take part in this study. Patients meeting the
following criteria are eligible for study entry:
 Over 18 years of age
 Suffering from chronic lower back pain of at least
three months duration
 Suitable for physiotherapy-led treatment
 Not requiring referral to any other department/service
 Classified as avoidant (defined as endorsing any of
the three psycho-social questions from the high-risk
sub-group on the Sub-groups for TargetedTreatment for Back Pain Screening Tool (STarT
Back) [16] and a score of 38 or more on the Tampa
Scale for Kinesiophobia (TSK) [17]
Patients meeting any of the following criteria will not
be eligible for study entry:
 Currently receiving psychological treatment
 Presence of sciatica (burning throbbing and
radiating leg pain of spinal origin confirmed by
performing the straight-leg raise test)
 Presence of a progressive disorder (for example,
chronic obstructive pulmonary disease (COPD),
cardiovascular disease, rheumatoid arthritis, lupus,
ankylosing spondylitis and neoplastic disease)
 Pregnancy
 Insufficient proficiency in English to comply with
treatment or provide data
 Involved in ongoing litigation relating to the pain
condition
Determining eligibility for participation will be a multi-
stage process; some of the eligibility criteria are established
upfront during review of the referral by the on-duty
physiotherapist (for example, age, duration of symptoms),
others during review of the completed screening question-
naire, telephone contact with the patient or during the
physiotherapy assessment. Rates of referrals, eligibility,
consent, and randomisation are monitored at each stage
to assess trial uptake.
Participant identification and recruitment process
The participant identification, recruitment and follow up
procedure is shown in Figure 1. In summary, all referrals
made to the musculoskeletal/physiotherapy services in-
volved in the study will be triaged. Those patients suit-
able will be asked to complete a screening questionnaire
and consent to be contacted by the researcher. Ques-
tionnaires will be sent out by post or given in-clinic. The
method used will be dependent on a centre's usual triage
and assessment procedures and the time lag between
referral and first appointment. If the responses provided
by the participant indicate that they are eligible, and if
they consent to being contacted, the researcher will con-
tact patients to further clarify eligibility. If eligible, the
patient is invited to attend a physiotherapy assessment
and a face-to-face meeting with the researcher. The
physiotherapy assessment will ensure that the participant
is not suffering from sciatica or any other progressive
disorders that may require a different clinical pathway.
Eligible patients will then meet face-to-face with the re-
searcher to learn more about the study, what participa-
tion involves, ask any questions they may have, and
provide written informed consent. Baseline data will be
Figure 1 Participant identification, recruitment and follow-up procedure.
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prior to randomisation.
It is made clear in all information provided to partici-
pants that they do not have to complete the question-
naire if they do not wish to, nor do they have to
participate in the trial. The patient can withdraw from
the study at any time and without prejudicing any fur-
ther treatment.Treatment
TAU – physiotherapy
A pragmatic approach of a class intervention in the form
of a Back-to-Fitness class has been implemented. Such
classes are commonplace in physiotherapy departments
across the UK. They are supported by the academic lit-
erature, and permit a degree of standardisation for the
purposes of an RCT.
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to 90 minutes, with a maximum of ten patients per class
spread out over a period of five weeks. Classes include
study participants and non-study participants. As classes
run several times a week, participants who miss a ses-
sion have the opportunity to re-schedule. Classes will be
delivered by a senior physiotherapist, and the timing and
location of the classes will be in line with each
department's routine procedures. The basic premise is
that exercise rather than a pain management interven-
tion should form at least 60% of each class. Classes will
include components such as: general fitness training, pa-
tient discussion, relaxation, goal setting, core stability,
stretching and exercises, pacing, self-management and
avoidance of recurrence. Participants will also be given
tips of the day and handouts. Classes can include educa-
tional elements such as discussions of fear avoidance,
but explicit use of CCBT or other psychological methods
designed to target fear and avoidance, such as systematic
exposure, or methods focused on enhancing psycho-
logical flexibility are to be avoided.
Prior to attending the Back-to-Fitness classes, partici-
pants may also require individual physiotherapy sessions
to prepare them to receive group therapy. The aim of
these individual sessions will be to tackle any issues that
may prevent patients from adhering to treatment, thus
minimising the chances of patients dropping out. The
number of individual physiotherapy sessions offered to
patients will be at the discretion of the physiotherapist
and will be dependent on issues such as severity of pain
and avoidance characteristics, but should not exceed
more than three individual sessions, each no more than
60 minutes in duration.
Intervention arm – CCBT
CCBT is an approach based on a functional contextual
theory of human behaviour and a general approach to
behavioural treatment called ACT. It seeks to create be-
haviour change by processes of identifying occasions
where behaviour patterns exhibit a quality of psycho-
logical inflexibility, and intervening with these occasions
to promote psychological flexibility. Psychological flexi-
bility is the capacity to persist with a behaviour pattern
or change it to effectively reach goals in a way that ap-
preciates what situations afford. One of the unique fea-
tures in applying psychological flexibility is that it
addresses dysfunctional cognitive influence not by
suggesting a change in the content of thoughts but by
seeking to reduce the exclusive dominance of cognitive
influence and by bringing behaviour more under the in-
fluence of direct experience.
Participants randomised to CCBT will receive a max-
imum of eight sessions (each lasting around 50 minutes)
with a Health and Care Professions Council-registeredpractitioner psychologist trained in the use of CCBT
methods for treating patients with chronic pain. The
first session will include initial work on demonstrating
an understanding of the patient's problems, building rap-
port and providing a basic description and rationale for
the treatment approach. Subsequent sessions will focus on
the use of experiential, exposure-based, and mindfulness-
based methods to enhance acceptance, a present-moment
focus, awareness, and values-based action. The number of
subsequent sessions will be determined by agreement be-
tween the patient and therapist that patient's goals have
been met. Goals-based ‘committed actions’ will be pro-
moted regularly, both in session and between sessions,
and built into integrated, generalised, and long-term pat-
terns of behaviour.
Therapists delivering CCBT are trained to competence
with an intensive two-day experiential workshop, com-
pletion of a currently available therapist training work-
book under supervision, and supervision of a series of at
least three individual patients with chronic lower back
pain by an expert in CCBT. The number of training
cases completed depends on how competent the therap-
ist is in delivering CCBT (each therapist can complete
up to five training cases). A core competency rating
form will be used in training to track therapists’ level of
developing skill for the delivery of CCBT [18]. To main-
tain faithful treatment delivery throughout the study,
supervision will be provided on a two-weekly basis with
extra supervision available for the first three patients
recruited at each centre to ensure treatment is being de-
livered optimally as per the CCBT treatment manual.
Supervision includes regular review of audio-taped CCBT
sessions.
Randomisation
Participants will be randomised on a 1:1 basis to receive
either CCBT or TAU and will be stratified by centre and
pain interference score [19-21]. Randomisation will
occur through the Clinical Trials Research Unit (CTRU)
24-hour automated randomisation system.
Randomisation of training cases
Participants will be randomised as training cases until
the CCBT trainer deems the therapist competent in the
delivery of CCBT. Randomisation of training cases is ne-
cessary to ensure therapists have a pool of participants
on whom to practice CCBT treatment methods.
Blinding
Participant and clinician blinding is not possible due to
the nature of the intervention; nor is researcher blinding,
as the researcher conducts a semi-structured interview
at three months, which includes treatment-specific
topics and questions.
Pincus et al. Trials 2013, 14:172 Page 6 of 10
http://www.trialsjournal.com/content/14/1/172Primary and secondary outcomes
The primary outcomes of interest include credibility and
acceptability of CCBT in the treatment of back pain, and
the feasibility of recruitment and completion of outcome
measures to the trial. These will be assessed as follows:
 Credibility of treatment to patients
∘ First two modified (prospective) questions of the
Borkovec and Nau questionnaire prior to
treatment (expectation) [22]
∘ Original Borkovec and Nau questionnaire at
three months (satisfaction) [22]
∘ Patient interview at three months: a qualitative
semi-structured interview with the researcher.
 Acceptability of treatment to patients
∘ Number of sessions attended
∘ Reasons for early withdrawal from treatment
∘ Patient interviews at three months
 Acceptability and credibility of the treatment to
therapists
∘ Interview at end of study
 Feasibility of recruitment process
∘ Number eligible for screening questionnaires
∘ Number of screening questionnaires completed
and returned
∘ Numbers attending interview with researcher
∘ Numbers randomised entered into the trial
∘ Reasons for non-participation and ineligibility
∘ A comparison of the postal and in-clinic
screening and recruitment methods
 Feasibility of assessment tools
∘ Time taken to complete questionnaires at all
time points
∘ Number of missing items
∘ Follow up rates
∘ Patient interviews at three months - acceptability
of measurement completion
 Proof of principle (process of change due to
treatment)
∘ Chronic Pain Acceptance Questionnaire (CPAQ)
[23] at three months
∘ Acceptance and Action Questionnaire-II (AAQ-II)
[24] at three months
The secondary outcomes (measured at three and six
months) include:
 Disability, measured by the Roland Morris Disability
Questionnaire (RDQ) [25].
 Pain, measured by Brief Pain Inventory (BPI)
[18-20]. Although CCBT does not aim to reduce
pain, a measurement of pain is needed to test the
randomisation process and be included as a
covariate in the final analysis. Fear of movement, measured by the TSK [17]. The
TSK measures the extent in which patients with
chronic pain experience fear of movement or injury/
re-injury.
 Mood measured using the Hospital Anxiety and
Depression Scale (HADS) [26]
 Quality of life measured by the Euroquol 5D
(EQ-5D™) [27,28] and the Short-Form 12
(SF-12V2™) [29].
 Recovery, measured by the Modified Patient Global
Impression of Change (MPGIC) [30,31].
The health economics section of this feasibility study
will assess the acceptability of obtaining resource use
data from patients about both personal and NHS costs
(a societal perspective). A de novo questionnaire based
on existing questions used in other back pain studies has
been developed. This questionnaire also includes a
short selection of questions to test the representative-
ness of the patient population against those reporting
musculoskeletal problems in the British Household Panel
Survey (BHPS).
Data collection
Table 1 details the information collected at the different
time points. Three- and six-month questionnaires will
be posted to the participants by the CTRU. The three-
month questionnaire includes a £10 voucher as an un-
conditional incentive. At the same time the CTRU will
prompt the researcher to remind the participant that
they will receive a questionnaire to complete, and ideally
this should be completed and returned before they meet
for the three-month interview. The CTRU will inform
the researcher if a questionnaire has not been returned
within two weeks, in which case the questionnaire will
be completed in the face-to-face interview. If the partici-
pant does not wish to be interviewed face-to-face and
has not completed the questionnaire the researcher will
attempt to complete the questionnaire with the partici-
pant over the telephone. Telephone completion will also
be offered to non-responding participants at the six-
month follow up.
The three-month interview schedule ascertains partici-
pant’s views on the acceptability and credibility of treat-
ment and the burden of questionnaire completion.
Monitoring treatment attendance and adherence
Treatment attendance
For both treatment arms, attendance at treatment ses-
sions is monitored via completion of a treatment attend-
ance form following all scheduled treatment sessions.
This form records the participants’ attendance and rea-
sons for non-attendance and participant withdrawal
from treatment (either by the therapist or participant
Table 1 Time points at which measures and data are collected
Screeninga Baseline During
treatment
Three month Six month
Gender X*
Age X*
Source of referral X*
Date of referral X*
Suitability for OBI (from information provided on referral) X*
Has the patient been sent a questionnaire? X*
BPI X X X X
(pain location only) (full) (full) (full)
TSK X X X
STarT Back X
Demographic information (age, gender, ethnicity) X
History of the pain condition X
Contact details X
CPAQ X X X
AAQ-II X X X
RDQ X X X
SF-12 X X X
EQ-5D X X X
HADS X X X
Expectation and satisfaction with treatment X X
(expectation) (satisfaction)
Date of each scheduled CCBT or physiotherapy session and whether
the session was attended
X
Reasons for non-attendance or early withdrawal X
Details of any concomitant treatments X
Details of any treatments the participant has been referred on to X
Recovery (MPGIC) X X X
Health economics X X X
Help questions (How long it has taken to complete the questionnaire?
Did anyone help you to complete the questionnaire?)
X X X X
Face-to-face interview X X
a An asterisk indicates that the data is collected for all patients triaged.
AAQ-II: Acceptance and Action Questionnaire II; BPI: Brief Pain Inventory; CCBT: Contextual Cognitive Behavioural Therapy; CPAQ: Chronic Pain Acceptance
Questionnaire; EQ-5D: Euroquol 5D; HADS: Hospital Anxiety and Depression Scale; MPGIC: Modified Patient Global Impression of Change; OBI: Optimised
Behavioural Intervention; RDQ: Roland Morris Disability Questionnaire; SF-12: Short Form 12; STarT Back: Sub-groups for Targeted Treatment for Back Pain
Screening; TSK: Tampa Scale for Kinesiophobia.
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participant has been referred on for other treatment.
Treatment adherence and integrity
In addition to the treatment attendance forms, for each
treatment session attended, a session rating form is also
completed by the treating physiotherapist or psycholo-
gist. These forms have been designed to ascertain which
components of the treatments were covered and are spe-
cific to the treatment arm. In the CCBT arm, all sessions
will also be audio-taped and a sample of these coded by
an independent reviewer, using an agreed rating scale
developed by the CCBT expert. To ensure treatmentadherence in the TAU arm, a sample of the physiother-
apy classes will be observed by the physiotherapy expert
and the components covered recorded.
Sample size
We plan to recruit 92 participants in total, randomised
equally to the TAU and CCBT arms. As this is a feasibility
study, formal power calculations are not appropriate, as
the study is not designed to test for a difference between
treatments. Recommendations for feasibility studies
propose that the analysis dataset comprises a minimum of
30 participants for each arm in order to estimate parame-
ters for future sample size calculations [32-34]. We
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loss to follow up will be no more than 35% (that is, 25%
due to loss to follow up and 10% due to non-compliance)
and therefore, aim to recruit 46 patients in each arm, to
account for potential missing data. Part of the rationale
for a feasibility study is to gather data to inform the design
of a definitive study; hence, estimates for non-compliance
and loss to follow up rates in this patient group will be
generated by the end of the study and will feed into power
calculations for the full trial.
Planned analyses
The analyses will be descriptive in nature and provide
estimates of key trial parameters for the definitive RCT.
A combination of qualitative and quantitative measures
will be used to address the research questions relating to
the acceptability and credibility of CCBT and the feasi-
bility of conducting a definitive trial in the future. Statis-
tical analyses will be on an intention-to-treat basis with
participants being analysed according to their random-
isation allocation. Data will be analysed at the end of the
study when all data collection, entry and validation is
completed. There are no planned sub-group analyses. As
this is a feasibility study, analysis will focus on confi-
dence interval estimation, rather than hypothesis testing.
Credibility data (expectation and satisfaction) will be
summarised by group and centre, together with 95%
confidence intervals. The number of participants missing
sessions, and withdrawal (from treatment, follow up or
both) in each arm will be reported overall, by centre and
by therapist.
The success of recruitment strategies will be measured
by summarising eligibility, consent and randomisation
rates, both overall and by centre. The burden of measure-
ment tool completion will be assessed by summarising fol-
low up rates and the time taken at baseline and follow up
for completion of the measurements. The level of missing
data (for individual items and for entire outcome mea-
sures) will also inform the assessment of measurement
tool acceptability.
Qualitative analyses will be carried out independently
by two researchers on transcripts from the interviews
conducted with consenting patients in each treatment
condition. We will use directed content analysis [35] to
explore consensus, and present the analysis backed by
verbatim quotes to illustrate main points. Errors, omis-
sions and commission will be discussed and resolved be-
tween the researchers.
To investigate the process of change and to generate
evidence of proof of principle, we will report mean
change from baseline in the three-month CPAQ scores
separately for the randomised groups with their 95%
confidence intervals. CCBT is expected to show a
greater change in the CPAQ than TAU. In addition, weuse exploratory plots and measures of correlations to in-
vestigate the relationship between levels of change in ac-
ceptance and disability at follow up.
Secondary outcome measures relating to quality of life,
mood, pain and global recovery post-treatment at six
months will be summarised by point estimates, variabil-
ity estimates and 95% confidence intervals presented by
randomised group at each time point.
Ethics and RD approval
A favorable ethical opinion was granted for this study by
the West London Research Ethics Committee (REF: 11/
H0706/9). Research governance approval for all partici-
pating sites was gained via the Coordinated System for
gaining NHS Permission. All information collected dur-
ing the course of the study will be kept confidential. In-
formation will be transferred, held securely on paper
and electronically, and archived in compliance with the
1998 Data Protection Act at the CTRU, Royal Holloway
University of London and at participating centres.
Trial governance
The Trial Management Group (TMG), comprising the
chief investigator, the CTRU team and co-investigators,
provides overall management of the study including clin-
ical set-up and training, centre set-up in preparation for
recruitment, promotion of the study and interpretation
of the results.
An independent Trial Steering Committee (TSC) pro-
vides independent and scientific oversight of the study
on behalf of the sponsor (Royal Holloway, University of
London) and the funder (Arthritis Research UK). The
TSC is composed of an independent chair and four
other independent members (including one lay member)
whose role it is to ensure the study is conducted in ac-
cordance with good clinical practice.
Discussion
The OBI study opened to recruitment in August 2011
and addresses an important gap in the evidence on how
to provide effective interventions for people with chronic
lower back pain, who are at high psychosocial risk. The
main issues encountered in the set-up and implementa-
tion have revolved around the training of psychologists
to deliver CCBT, the development of effective recruit-
ment processes that fit across all sites (which vary sig-
nificantly in their structure and function) and the
development of successful strategies to procure three-
and six-month follow up data from this difficult high-
risk patient population. Despite these issues the trial is
recruiting well and invaluable information has been
gathered about the design and logistical issues that will
inform the design, set-up and implementation of a de-
finitive RCT. Feasibility studies, therefore, play an
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is achieved through a well-thought-out and conducted
study with clear aims and objectives, which result in
higher quality, well-designed definitive RCTs.
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